May 20, 2023 Comments Off on New patent for Astrazeneca drug LYNPARZA Posted in: Patent Added Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent for Astrazeneca drug LYNPARZA appeared first…
May 19, 2023 Comments Off on New patent for Galderma Labs drug EPSOLAY Posted in: Patent Added Annual Drug Patent Expirations for EPSOLAY Epsolay is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Galderma Labs drug EPSOLAY appeared first on DrugPatentWatc…